tbuckley/cabot-search huggingface dataset:
A Meta-analysis of Estrogen Replacement and Breast Cancer-Reply
Authors: Karen K. Steinberg
Journal: JAMA (1991)

<h3>In Reply.</h3> —Drs Mendlovic and Kleerekoper suggest that we should report risk estimate for 15 years of estrogen use calculated on the basis of the US studies only. We did report an estimate for the proportional increase in risk per year for the 13 US studies (0.010, 95% confidence interval [CI], 0.002, 0.017; 15-year risk estimate, 1.2). We cannot conclude from this, however, that the increased risk is due to the European studies. Other factors, such as study quality or inclusion of premenopausal women, may have accounted for higher risk estimates. For example, when we excluded the European studies, we found that the mean proportional increase in risk for the highest-scoring tertile of the remaining studies was 0.024 (CI, 0.007, 0.040), which gave an RR of 1.4 after 15 years, while the two lower-scoring tertiles did not show increased risk. With regard to Dr Katerndahl's question about publication bias, we
ROTATION OF HOSPITAL SERVICES.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
On federal regulation of methadone treatment
Authors: V. P. Dole
Journal: JAMA (1995)

A RECENT report from the Institute of Medicine (an affiliate of the National Academy of Sciences) provides an authoritative review of the history and consequences of federal regulation of methadone treatment.<sup>1</sup>It examines the assumptions that justified imposition of special restrictions on prescription of methadone and the effects of enforced guidelines on the function of treatment programs. Since the Narcotic Addict Treatment Act (1974) authorized an unprecedented restriction of the right of physicians to prescribe an approved drug, the experience of the past 20 years can be seen as a major experiment in governmental regulation of medical practice. Given the controversial nature of the subject, both the government and the medical profession in general are fortunate to have had the results of this experiment evaluated at the highest scientific level. Quite properly, I was not included in the deliberations for the Institute of Medicine report. My views on the
PYRETHRUM DERMATITIS
Authors: JAMES H. SEQUEIRA
Journal: British Journal of Dermatology (1936)

Journal Article PYRETHRUM DERMATITIS Get access JAMES H. SEQUEIRA, M.D., F.R.C.P.LOND., F.R.C.S.ENG. JAMES H. SEQUEIRA, M.D., F.R.C.P.LOND., F.R.C.S.ENG. Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology and Syphilis, Volume 48, Issue 10, 1 October 1936, Pages 473–476, https://doi.org/10.1111/j.1365-2133.1936.tb10284.x Published: 01 October 1936
POPULATION GROWTH
Authors: John Rock
Journal: JAMA (1961)

Worth the attention of all physicians is the document presented to the United Nations on November 17, 1960, by Sir Julian Huxley, distinguished British biologist, and Mr. Cass Canfield, publisher. They did this on behalf of more than 200 scientists, statesmen, and humanitarians from many countries who urged the United Nations to "take the lead in establishing and implementing a policy designed to limit population growth the world over—in order that human beings everywhere may grow on a qualitative rather than on a merely quantitative level, and in order that they may be assured of the opportunity to develop their highest capacities, and to enjoy individual freedom, the advantages of education and public health, privacy, abundance, security, and the beauty and wonder of the world." This forthright petition followed reiteration of some ecological facts, glaringly clear to unprejudiced minds. These demonstrate, as the statement puts it, that "unless a favorable balance
Classified Advertising
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
"Delicensed" Physician.
Authors: Elmer E. Rogers
Journal: JAMA (1906)

Chicago, July 17, 1906. <h3>To the Editor:</h3> —In a magazine article, having occasion to use an adjective descriptive of a physician with license revoked, I coined "delicensed physician." This term has met no serious objections from the medical profession (I am a practicing lawyer) and as the authorities contain no explicit term for that purpose, I suggest this word. I tried to write this grouping in a sentence, "disbarred lawyer, delicensed physician, suspended clergyman." The sentence is far from pleasing when "physician with license revoked," is used in connection with suspended or expelled clergyman and disbarred lawyer.
NIH panel finds embryo research justifiable, recommends support
Authors: C. Marwick
Journal: JAMA (1994)

THE US GOVERNMENT is being urged to fund research into the beginnings of human life. A panel convened by the National Institutes of Health (NIH), Bethesda, Md, has recommended that carefully guided investigations into the fertilized human embryo can be justified and are worth federal support. Properly designed studies could enlarge scientific knowledge in a variety of reproductive areas, including infertility, genetic diseases, contraception, and cancer, the panel concludes. Research would be limited to embryos 14 days or less from first cell division. At this point, the embryo develops the so-called primitive streak, a faint white trace at the caudal end of the embryonic disk that provides the earliest evidence of the embryonic axis, or spatial orientation. The panel's report is a milestone. It brings the United States into line with other countries that have addressed the issue of human embryo research in one way or another, rather than simply
Last Call for AMA-RPS Annual Meeting Resolutions
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Combined screening: blood pressure and cholesterol
Authors: N. B. Record
Journal: JAMA (1987)

<h3>In Reply.—</h3> Dr Hainer raises a legitimate question that is not discussed in our article. Adjusting for the problem of regression to the mean produces results similar to those presented there, however. The following analysis adjusts for the fact that individuals with higher cholesterol levels are more likely to experience a decline in cholesterol level. The analysis uses the same data set and age groups as in Table 4 of our article. Two variables are considered: (1) the maximum cholesterol level over the first eight Framingham study examinations and (2) the percent fall from this maximum to the cholesterol level observed at examination 8. Cox regressions using stratification by age group and maximum cholesterol level (grouped into 20 mg/dL—wide categories) with percent fall from maximum as the independent variable were performed (Table). This stratification compares mortality only within the age and maximum cholesterol level categories and thus lessens or eliminates
FRI0161 Humoral and cell-mediated immune response to cow’s milk proteins in behÇet’s disease
Authors: G Triolo, A Accardo-Palumbo, F Ciccia, A Ferrante, C Mantione, E Giardina, G Licata
Journal: Annals of the Rheumatic Diseases (2001)

<h3>Background</h3> Behçet's disease (BD) is a multisystemic inflammatory disease characterised by a number of immunological variables. The relevance of these findings is not sufficient to support an autoimmune pathogenesis. Consumption of cow's milk proteins might be a risk factor for the development of autoimmune disease. <h3>Objectives</h3> To investigate the humoral and cell-mediated immune response against cow's milk proteins in BD. <h3>Methods</h3> Sera from 47 patients with BD and 38 healthy subjects were studied. Anti beta-casein (bC) and anti beta-lactoglobulin (bLG) antibodies were detected by ELISA. Peripheral blood mononuclear cells from 16 BD patients and from 8 healthy controls were cultured in the presence of PHA, beta-casein or beta-lactoglobulin and IL-4 and Interferon-gamma measured in the culture supernatants by ELISA. <h3>Results</h3> Significant higher levels of anti-bC and anti-bLG were found in the sera of patients with active disease (anti-bC-IgA:1.89 ± 2.2 SDU;-IgG:3.64 ± 5.93; anti-bLG-IgA:2.07 ± 2.51;-IgG:1.72 ± 2.7) compared with those of inactive patients (anti-bC-IgA:0.68 ± 0.92;-IgG:0.83 ± 1.26; anti-bLG-IgA:0.70 ± 1.12;-IgG:0.37 ± 0.65) or controls. Higher levels of IFN-gamma but not IL-4 were found in the supernatants of active patient cultures but not in those of patients with inactive disease or controls in both bC and bLG studies. Levels were comparable to those obtained with PHA. <h3>Conclusion</h3> The occurrence of anti-bC and anti-bLG in BD and studies on the cellular immune response with Th1 cytokine secretion might further support the putative role of cow's milk protein immune response in the pathogenesis of autoimmune disease and in particular of BD.
Clinical Endocrinology
Authors: James V. Felicetta
Journal: JAMA (1987)

This text is primarily intended as a ready reference book both for house officers and for practicing clinicians. As such, it fits nicely into its own niche somewhere between the longer endocrine texts such as Williams and the clinical pocket manuals of endocrinology. Compared with some other endocrine treatises, this book focuses more heavily on the practical clinical aspects of endocrinology, but it handles them in an authoritative and definitive fashion. The biochemical and physiological aspects of endocrinology are discussed primarily as they bear directly on the clinical approach to endocrine problem solving. Considerable space is devoted in each chapter to a discussion of relevant clinical tests available in each area of endocrinology, and the various authors have done a commendable job of placing the different diagnostic options in proper perspective. The contributors are generally wellrecognized senior academicians who have themselves made major research contributions to endocrinology. The text is
All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.
Authors: Richard F. Schlenk, Konstanze Dohner, Martina Kerz, Francisco del Valle, Björn Heydrich, Ingo Schmidt-Wolf, Hans Pralle, Katharina Götze, Elisabeth Koller, David Nachbaur, Hans G. Mergenthaler, Walter Fiedler, Detlef Haase, Stephan Kremers, Matthias Theobald, Axel Matzdorff, Arnold Ganser, Hartmut Dohner
Journal: Blood (2006)
AMA Specialty Journal Abstracts
Journal: JAMA (1991)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Bone Tumors
Authors: Lent C. Johnson
Journal: JAMA (1966)

The first edition of this book, appearing in 1952, represented the first major treatise on bone tumors since Geschickter and Copeland's text. The second edition in 1959, larger by some 82 pages, added chapters on periosteal lesions, osteoblastomas and joint lesions. The current edition is now larger by 27 additional pages, which include a new chapter on unusual benign and malignant chondroid tumors. Not everyone will agree with the interpretations offered here, as the author points out, but it is appropriate that these lesions be recognized. All chapters show evidence of updating on the basis of additional information. The book is primarily a pathology text, emphasizing radiologic and gross appearance and histology. Appropriate remarks, correlating clinical findings and follow-up studies with treatment, are included. The lucid writing makes for comfortable reading, and illustrations are well chosen and clear. The discussion of treatment of osteogenic sarcoma recognizes the challenge of Green's
Ulcerative Colitis
Authors: William R. Barclay
Journal: JAMA (1979)

Ulcerative colitis is a chronic, serious, disabling disease that imposes a serious burden on patients, their families, and the physicians who manage this condition. The disease is frequently diagnosed by the primary care physician, and although a referral may be made for special care, most patients continue to be seen by their family physician or general internist. This book was written as a guide for the generalist rather than the specialist and is an excellent description of the diagnosis, treatment, pathology, complications, and long-term care of ulcerative colitis. Within its 200 pages a physician can quickly locate the answer to most questions that arise in the management of this disease. This is a highly recommended book.
NEW YORK STATE MEDICAL ASSOCIATION.
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hemophilia A
Authors: Leon W. Hoyer
Journal: New England Journal of Medicine (1994)

The dramatic hemorrhages, the effect of the disease on history through its presence in Queen Victoria's descendants, and the devastating role of therapeutic concentrates in the transmission of the acquired immunodeficiency syndrome (AIDS) have made hemophilia A the object of great medical, scientific, and public interest. The commonest hereditary coagulation disorder and a disease without ethnic or geographic limitations, its incidence approaches 20 per 100,000 male births13. John Conrad Otto emphasized its inheritance as an X-linked disorder in his 1803 description of the disease in a New Hampshire family: "males only are subject to this strong affection . . . .
NIH Sources Listed for Information About the 185delAG Alteration in the BRCA1 Gene
Journal: JNCI Journal of the National Cancer Institute (1995)

Journal Article NIH Sources Listed for Information About the 185delAG Alteration in the BRCA1 Gene Get access JNCI: Journal of the National Cancer Institute, Volume 87, Issue 19, 4 October 1995, Page 1440, https://doi.org/10.1093/jnci/87.19.1440 Published: 04 October 1995
The use of child restraint devices in vehicles
Authors: A. K. Fuller
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Laryngoscope, St. Louis
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Blood pressure and metabolic effects of calcium supplementation in normotensive white and black men
Authors: R. M. Lyle
Journal: JAMA (1987)

A randomized, double-blind, placebo-controlled trial was conducted to examine the effect of calcium supplementation on blood pressure in normotensive black (n = 21) and white (n = 54) men, aged 19 to 52 years. After a four-week baseline period of weekly blood pressure measurement, subjects were randomly assigned within racial groups to either a treatment (calcium, 1500 mg/d) or placebo group for a 12-week period. During the experimental period, multiple blood pressure measurements were taken every two weeks in both the seated and supine positions, using a random baseline sphygmomanometer. A repeated-measures analysis of covariance yielded a modest but significantly lower seated mean arterial pressure in the treatment group compared with the control group, but no differences between the races. Results were similar for supine blood pressure. Calcium supplementation, in comparison with placebo, resulted in lower mean arterial pressure in normotensive white and black men during a 12-week period. The overall blood pressure—lowering effect was not correlated with the response of serum levels of total and ionized calcium, total inorganic phosphorus, or parathyroid hormone, or overnight urinary electrolyte values. (<i>JAMA</i>1987;257:1772-1776)